86 results on '"Tosetto, A."'
Search Results
2. More early bleeds associated with high baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
3. Inhibitor development according to concentrate after 50 exposure days in severe hemophilia: data from the European HAemophilia Safety Surveillance (EUHASS)
4. Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillation: the MAS study
5. Caspase-4 Has Potential Utility as a Colorectal Tissue Biomarker for Dysplasia and Early-Stage Cancer
6. Venous thromboembolism secondary to hospitalization for COVID-19: patient management and long-term outcomes
7. von Willebrand factor neutralizing and non-neutralizing alloantibodies in 213 subjects with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
8. Rivaroxaban for the treatment of noncirrhotic splanchnic vein thrombosis: an interventional prospective cohort study
9. Von Willebrand factor propeptide and pathophysiological mechanisms in European and Iranian patients with type 3 von Willebrand disease enrolled in the 3WINTERS‐IPS study
10. Turoctocog alfa pegol (N8‐GP) in severe hemophilia A: Long‐term safety and efficacy in previously treated patients of all ages in the pathfinder8 study
11. Surgical management of patients with von Willebrand disease: summary of 2 systematic reviews of the literature
12. D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study
13. Genotypes of European and Iranian patients with type 3 von Willebrand disease enrolled in 3WINTERS-IPS
14. ASH ISTH NHF WFH 2021 guidelines on the management of von Willebrand disease
15. Bleeding symptoms in patients diagnosed as type 3 von Willebrand disease: Results from 3WINTERS‐IPS, an international and collaborative cross‐sectional study
16. Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC
17. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD‐VTE patients
18. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment
19. Fixed doses of N8‐GP prophylaxis maintain moderate‐to‐mild factor VIII levels in the majority of patients with severe hemophilia A
20. The American College of Chest Physician score to assess the risk of bleeding during anticoagulation in patients with venous thromboembolism
21. Phase 1, single‐dose escalating study of marzeptacog alfa (activated), a recombinant factor VIIa variant, in patients with severe hemophilia
22. Rivaroxaban vs warfarin in high-risk patients with antiphospholipid syndrome
23. External validation of the DASH prediction rule: a retrospective cohort study
24. PB0473 VTE Outcomes in Patients Treated with Direct Oral Anticoagulants and Concurrent Antiepileptic Drugs: Data from the START2 and the RIETE
25. Safety of vitamin K antagonist treatment for splanchnic vein thrombosis: a multicenter cohort study
26. Risk of recurrence after a first unprovoked venous thromboembolism: external validation of the Vienna Prediction Model with pooled individual patient data
27. How I treat type 2 variant forms of von Willebrand disease
28. Thrombotic risk in patients with primary immune thrombocytopenia is only mildly increased and explained by personal and treatment‐related risk factors
29. EP.12B.03 Cognitive Impact of Lorlatinib Administration in Advanced Non Small Cell Lung Cancer with ALK and ROS1 Fusions
30. Bleeders, bleeding rates, and bleeding score
31. Standardization of bleeding assessment in immune thrombocytopenia: report from the International Working Group
32. Patient-level compared with study-level meta-analyses demonstrate consistency of D-dimer as predictor of venous thromboembolic recurrences
33. Phase III studies on novel oral anticoagulants for stroke prevention in atrial fibrillation: a look beyond the excellent results
34. Validation of the Hematopoietic Cell Transplantation-Specific Comorbidity Index: a prospective, multicenter GITMO study
35. Long‐term outcomes of patients with cerebral vein thrombosis: a multicenter study
36. Predicting disease recurrence in patients with previous unprovoked venous thromboembolism: a proposed prediction score (DASH)
37. Different bleeding risk in type 2A and 2M von Willebrand disease: a 2‐year prospective study in 107 patients
38. Tu1200 INTEGRATION OF IN SILICO AND IN VITRO FUNCTIONAL ANALYSIS REVEALS TISSUE FACTOR PATHWAY INHIBITOR 2 (TFPI2) AS A MASTER TRANSCRIPTIONAL REGULATOR AND POTENTIAL TARGET TO IMPEDE INFLIXIMAB RESISTANCE IN ADULT UC PATIENTS
39. Prospective evaluation of the clinical utility of quantitative bleeding severity assessment in patients referred for hemostatic evaluation
40. Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient‐level meta‐analysis
41. Thrombophilic mutations and cardiovascular disease: the case is still open
42. ISTH/SSC bleeding assessment tool: a standardized questionnaire and a proposal for a new bleeding score for inherited bleeding disorders
43. Sex, age and normal post‐anticoagulation D‐dimer as risk factors for recurrence after idiopathic venous thromboembolism in the Prolong study extension
44. Usefulness of repeated D-dimer testing after stopping anticoagulation for a first episode of unprovoked venous thromboembolism: the PROLONG II prospective study
45. Molecular and phenotypic determinants of the response to desmopressin in adult patients with mild hemophilia A
46. How I treat von Willebrand disease
47. Trial of Rivaroxaban in AntiPhospholipid Syndrome (TRAPS): Two‐year outcomes after the study closure
48. Reduced von Willebrand factor survival in von Willebrand disease: pathophysiologic and clinical relevance
49. von Willebrand disease: proposing definitions for future research
50. Lenalidomide Maintenance after VTD Induction and Autologous Stem Cell Transplantation: An Italian Real-Life Study of 558 Patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.